Wilmington, Delaware, United States, July 22, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc.: An in-depth digital dose inhalers market insight reveals that smart inhalers are helpful in enhancing medication adherence in patients with chronic respiratory diseases. In particular, the awareness about the effective of such technologies is growing among patients with chronic obstructive pulmonary disease (COPD) and asthma. The digital dose inhalers market size is projected to expand at a CAGR of 12.5% from 2022 to 2031.
A granular digital dose inhalers market analysis presented in a TMR study found that the integration of patients’ data with EHR (electronic health records)/EMR (electronic medical records) has opened up new strategies in the management of COPD. Stakeholders are gearing toward raising the awareness about adequate use of digital inhalers. Of note, they are increasingly focused on educating elderly population in developing economies about the affordability of inhalation delivery systems.
Recent developments in the digital dose inhalers have underscored the penetration of metered-dose inhalers especially in the U.S. and Europe, thus expanding the commercialization of products in the digital dose inhalers market. The need for simplified and reliable ways of tracking medication adherence in chronic respiratory diseases will shape the future outlook of the digital dose inhalers market.
Request Brochure of Digital Dose Inhalers Market Research Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18881
Key Findings of Digital Dose Inhalers Market
- Prevalence of Asthma and COPD to Spur Penetration of Products: Advancements in digital inhaler health platforms are enriching the value chain of companies in the digital dose inhalers market. Their role in boosting adherence to inhaled therapies among patients with COPD and asthma has opened value-grab opportunity for market players. New technologies enable monitoring of adherence in that the patients and clinicians can obtain data on inhaler actuation and sometimes on techniques through the use of add-on or embedded sensors. These product attributes will continue to attract demand, thus expanding digital dose inhalers market size.
- Uptake of Metered Dose Inhalers Steering Substantial Revenues: The past few years have witnessed rising adoption of metered dose inhalers in hospital settings, mainly due to high risks of COVID-19 infections in patients with respiratory diseases. The study reiterates that meter dose inhalers is a remarkably lucrative segment in the digital dose inhalers market. It held a major share and the products are anticipated to witness widespread penetration among the patient population.
- Demand for Digital Inhalers Among Asthma Patients Underpins Enormous Opportunity: Digital technologies have opened new strategies for the management of patients with asthma as their use in e-health is crucial. Strides in e-health will thus expand the window of opportunities A number of products have gained approvals over the past few years, especially from the U.S. FDA, thus enriching the prospects of the digital dose inhalers market.
Request for Analysis of COVID-19 Impact on Digital Dose Inhalers Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=18881
Digital Dose Inhalers Market: Key Drivers
- Prevalence of chronic respiratory diseases pose high global health burden, particularly COPD and asthma. Of note, incidence and prevalence of asthma have increased across all demographics worldwide over the past few decades. The burden of asthma is a key driver for expanding prospects of the digital dose inhalers market.
- Growing awareness about the benefits of smart digital inhalers to patients is a key underpinning propelling the evolution of the digital dose inhalers market
Get Exclusive PDF Sample Copy of Digital Dose Inhalers Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18881
Digital Dose Inhalers Market: Regional Growth Dynamics
- North America held a major share of the global digital dose inhalers market. The region has witnessed the commercialization of digital systems over the past few years. High prevalence of COPD and asthma and the awareness of their mortality are catalyzing expansion of product portfolio of leading global players in the regional market.
- Asia Pacific is witnessing enormous potential revenues. The TMR study projects the regional market to expand at the highest CAGR during the forecast period. High burden of asthma is one of the key trends fueling the prospects.
Digital Dose Inhalers Market Key Players
Some of the key players in the market are H&T Presspart, Cipla, Inc., AptarGroup, Inc., Sensirion AG, 3M, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Glenmark, AstraZeneca, and Novartis AG.
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=18881
Digital Dose Inhalers Market Segmentation
- Product
- Metered Dose Inhalers
- Dry Powder Inhalers
- Application
- Asthma
- COPD (chronic obstructive pulmonary disease
- Others
Regions Covered
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Countries Covered
- U.S.
- Canada
- Germany
- U.K.
- France
- Italy
- Spain
- China
- India
- Japan
- Australia & New Zealand
- Brazil
- Mexico
- GCC Countries
- South Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
CINV Existing and Pipeline Drugs Market: The global CINV existing and pipeline drugs market is expected to surpass value of US$ 3.2 Bn by the end of 2031.
Wound Irrigation Systems Market: The global Wound Irrigation Systems Market revenues are projected to reach more than US$ 419.1 Mn by 2031 with a CAGR of 4.0% during 2022–2031.
Antihypertensive Drugs Market: The global antihypertensive drugs market is anticipated to reach more than US$ 40 Bn by the end of 2031.
Erectile Dysfunction (ED) Drugs Market: The global erectile dysfunction (ED) drugs market is expected to reach the value of US$ 2.5 Bn by the end of 2028.
Oral Transmucosal Drugs Market: The global oral transmucosal drugs market was valued over US$ 14 Bn in 2020 and is projected to expand at a CAGR of ~6% from 2021 to 2031.
Hydroxychloroquine Drugs Market: The hydroxychloroquine drugs market is predicted to clock a robust CAGR of 10% during the forecast period. The global hydroxychloroquine drugs market is expected to cross US$ 1.9 Bn by 2030.
Veterinary Dermatology Drugs Market: The global veterinary dermatology drugs market was valued over US$ 3.6 Bn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031.
Respiratory Virus Infection Drugs Market: The respiratory virus infection drugs market is expected to surpass a value of US$ 82.4 Bn by the end of 2030.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and business consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
